Stockscreener 앱 받기
47.81
0.08%
-0.0377
전일 마감가:
$47.85
열려 있는:
$47.98
하루 거래량:
5,930
Relative Volume:
0.54
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.94%
1개월 성능:
+3.41%
6개월 성능:
+37.62%
1년 성능:
+24.41%
1일 변동 폭
$47.71
$48.23
1주일 범위
$46.67
$48.38
52주 변동 폭
$27.20
$48.92
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
47.81 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.85 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.66 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.66 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.53 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
621.26 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf 주식(GNOM)의 최신 뉴스
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
FengHe Fund Management Pte. Ltd. Invests $36.48 Million in Ciena Corporation $CIEN - Defense World
Invesco BulletShares 2025 Corporate Bond ETF $BSCP Shares Bought by Farnam Financial LLC - Defense World
Schwab US Large-Cap ETF $SCHX is Farnam Financial LLC’s Largest Position - Defense World
FengHe Fund Management Pte. Ltd. Invests $49.61 Million in Analog Devices, Inc. $ADI - Defense World
Clarity Wealth Advisors LLC Has $9.09 Million Stock Position in JPMorgan Core Plus Bond ETF $JCPB - Defense World
Vanguard Small-Cap ETF $VB Shares Acquired by Farnam Financial LLC - Defense World
Vanguard FTSE Developed Markets ETF $VEA Shares Bought by Farnam Financial LLC - Defense World
70,027 Shares in Intel Corporation $INTC Acquired by Farnam Financial LLC - Defense World
How to Buy CRISPR Therapeutics Stock (CRSP) - The Motley Fool
Allspring Global Investments Holdings LLC Sells 1,180,416 Shares of Alight, Inc. $ALIT - Defense World
(GNOM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Archford Capital Strategies LLC Sells 21,216 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Armbruster Capital Management Inc. Has $54.56 Million Holdings in Vanguard U.S. Value Factor $VFVA - Defense World
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Global X FundsGlobal X Genomics & Biotechnology ETF announces Semi-Annual dividend, payable on January 07, 2026 - marketscreener.com
Acacia Research (NASDAQ:ACTG) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The Next Big Theme: December 2025 - Seeking Alpha
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Touchstone Climate Transition ETF (OTCMKTS:HEAT) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
5 Small-cap Biotech ETFs to Watch - Investing News Network
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
Flow Traders U.S. LLC Buys 82,063 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Flow Traders U.S. LLC Has $1.71 Million Position in Avantis Short-Term Fixed Income ETF $AVSF - Defense World
Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Biglari (NYSE:BH) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The Next Big Theme: November 2025 - Global X ETFs
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Flowserve (NYSE:FLS) Rating Lowered to Buy at Wall Street Zen - Defense World
Why (GNOM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Understanding Momentum Shifts in (GNOM) - news.stocktradersdaily.com
Atria Investments Inc Boosts Stake in Global X Genomics & Biotechnology ETF $GNOM - Defense World
Global X Genomics & Biotechnology ETF (GNOM) Stock Price Quote Today & Current Price Chart - Capital.com
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
Biotechnology: Pioneering The Future Of Medicine - Seeking Alpha
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Biotechnology: Pioneering the Future of Medicine - Global X ETFs
The Best Performing ISA ETFs This Month - home.saxo
Astoria US Quality Growth Kings ETF (NASDAQ:GQQQ) Sees Large Increase in Short Interest - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update - Defense World
First Trust Health Care AlphaDEX Fund (NYSEARCA:FXH) Short Interest Up 187.5% in September - Defense World
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
The Next Big Theme: October 2025 - Seeking Alpha
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - MSN
The Best Biotech ETFs to Buy - Kiplinger
Global X Genomics Biotechnology Etf (GNOM) 재무 분석
Global X Genomics Biotechnology Etf (GNOM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.02%
0.27%
자본화:
|
볼륨(24시간):